What is a “Modified Nucleotide” according to MPEP 2412.03(e)?

According to MPEP 2412.03(e), a “Modified nucleotide” is defined as follows:

“Modified nucleotide” includes any nucleotide as described in paragraph 3(f) of WIPO Standard ST.26.

Further explanation from WIPO Standard ST.26 states that a modified nucleotide is any nucleotide other than the standard DNA and RNA nucleotides. Specifically, it excludes:

  • deoxyadenosine 3′-monophosphate
  • deoxyguanosine 3′-monophosphate
  • deoxycytidine 3′-monophosphate
  • deoxythymidine 3′-monophosphate
  • adenosine 3′-monophosphate
  • guanosine 3′-monophosphate
  • cytidine 3′-monophosphate
  • uridine 3′-monophosphate

To learn more:

Topics: MPEP 2400 - Biotechnology, MPEP 2412.03(E) - "Modified Nucleotide", Patent Law, Patent Procedure
Tags: Biotechnology, Modified Nucleotide, nucleotide sequence, wipo standard st.26